HMDG has confirmed the creation of an independent Advisory Board, marking a significant step in strengthening governance, clinical oversight and ethical decision-making as the organisation expands within private healthcare and MSK services.
Although the Advisory Board has now been formally established, HMDG has long drawn on informal external advice. Since its early days, the business has engaged senior clinicians and experienced industry professionals to scrutinise ideas, challenge internal thinking and provide independent perspective prior to launching new initiatives. The new Board introduces a clear, accountable structure to that long-standing approach.
Founded on strong clinical principles, HMDG has always combined commercial expertise with deep sector knowledge. As the business grew to operate at national scale, leadership recognised the need for more structured and independent oversight. The Advisory Board has been created to ensure consistent challenge and guidance as part of the company’s long-term governance model.
The Board has been tasked with several core functions, including reviewing initiatives before they reach the market, acting as a strategic sounding board for senior leaders, challenging organisational assumptions and ensuring decisions align with clinical best practice, patient outcomes and ethical responsibility.
Jack Chew, who has served as a trusted clinical advisor to HMDG, was asked to support the formation of the Board. He worked with the company to identify a small group of individuals with complementary experience across clinical delivery, leadership, operations and healthcare innovation.
Lucy Macdonald joins the Board bringing experience as both a practising physiotherapist and healthcare entrepreneur. She is the Lead Physiotherapist and Founding Director of Restart Physio in Surrey and has previously built and exited private clinics. In addition, she holds a number of non-executive, consultancy and media roles within the healthcare sector.
Nicola Graham also becomes part of the Advisory Board, contributing expertise from across NHS practice, elite sport and private healthcare. After owning and exiting a multidisciplinary healthcare business, she now works in fractional and board roles in preventative health, human performance and sports technology, supported by an Executive MBA.
Ove Indergaard brings nearly three decades of MSK experience to the Board. As Founder and Chief Executive of Indergaard Physiotherapy Ltd, he leads a multi-site clinic group in northern England and is widely recognised for his international work in Shockwave Therapy education and clinical governance.
Completing the Advisory Board is Laura Beaven, a chiropractor by training and Co-Founder and Chief Operating Officer of Dyer Street Clinic. She played a central role in scaling the organisation from a small practice into a multidisciplinary clinic employing more than 20 people.
Commenting on the announcement, HMDG CEO Ben Marcilhacy said: “As HMDG has grown, so has its responsibility to the sector. The Advisory Board exists to ensure decisions are challenged, standards remain high, and the business continues to act in a way that is clinically credible and ethically grounded.”
HMDG has confirmed that the Advisory Board will operate as a permanent governance mechanism, supporting transparency, accountability and ongoing improvement as the organisation continues to develop.
About HMDG
HMDG is a healthcare marketing and strategy company specialising in the private healthcare and MSK sector. The business works with clinic owners to develop sustainable growth strategies that are aligned with clinical standards, patient outcomes, and long-term operational viability.
